Politics

As predicted, members of the Senate Intelligence Committee came out swinging early today with several questions for acting FBI Director McCabe on whether the Trump administration was actively seeking to impede an investigation into Russian meddling in the 2016 election.  Unfortunately, McCabe's answers will undoubtedly be somewhat disappointing for Democrats and CNN.

In an early exchange with Senator Marco Rubio, McCabe offered a very succinct answer on alleged White House interference with ongoing FBI investigations:

Via The Daily Bell

The President is very much a figurehead – he wields no real power whatsoever. He is apparently chosen by the government, but the qualities he is required to display are not those of leadership but those of finely judged outrage. For this reason the President is always a controversial choice, always an infuriating but fascinating character. His job is not to wield power but to draw attention away from it.

An orange sash is what the President of the Galaxy traditionally wears.

Background.

The Sun claims that CNN has released new footage of last month’s Syrian chemical incident … and strongly implies that the Syrian government was responsible.

Washington’s Blog asked MIT rocket scientist and chemical weapons expert Theodore Postol* what he thought of the footage.

Postol replied:

I agree that the footage is harrowing. However none of it is new and none of it proves that the Syrian government was the perpetrator of a nerve agent attack.

 

According to a White House official, Bloomberg is reporting that President Donald Trump is considering Mike Rogers, a former congressman and FBI agent from Michigan, to replace James Comey as FBI director.

Rogers, 53, a former chairman of the House Intelligence Committee, retired from Congress in 2015 after seven terms to pursue a career in talk radio.

Authored by Mike Shedlock via MishTalk.com,

Bye bye, so long farewell, Aetna fully exits Obamacare exchanges with pull-out in two states

Health insurer Aetna Inc said on Wednesday it will exit the 2018 Obamacare individual insurance market in Delaware and Nebraska – the two remaining states where it offered the plans.

 

Aetna had already said it would exit the individual commercial market in Virginia and Iowa, after pulling out of several other states last year.